The Oncology Institute, Inc. (NASDAQ:TOIIW) Sees Significant Drop in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the target of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 1,700 shares, a decline of 45.2% from the December 15th total of 3,100 shares. Based on an average daily trading volume, of 24,200 shares, the short-interest ratio is presently 0.1 days.

Oncology Institute Stock Performance

TOIIW traded down $0.00 during trading on Thursday, hitting $0.02. 45,954 shares of the company’s stock traded hands, compared to its average volume of 25,915. The company’s 50 day simple moving average is $0.01 and its two-hundred day simple moving average is $0.02. Oncology Institute has a 12-month low of $0.01 and a 12-month high of $0.37.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.